Skip to content

Long-term Surgical Therapeutic Outcomes of Peri-Implantitis

Long-term Surgical Therapeutic Outcomes of Peri-Implantitis

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03772652
Enrollment
38
Registered
2018-12-11
Start date
2018-12-04
Completion date
2020-02-13
Last updated
2022-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis

Brief summary

This study focuses on evaluating the success of different treatment methods for peri-implantitis (gum disease around implants) and to understand the factors that might affect the success of the treatment provided.

Detailed description

Qualifying patients will be asked to participate in clinical measurements to compare the long-term success of their treatments. The aims of the current study are to 1) assess the long-term outcome of the surgical treatment of peri-implantitis and to 2) evaluate the success of the different treatment modalities of peri-implantitis.

Interventions

OTHERObservation

Soft tissue implant measurements

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

1. The patient is at least 18 years of age, 2. was initially diagnosed with peri-implantitis at ≥1 implant (peri-implant probing depth (PPD) ≥ 6 mm together with bleeding and/or suppuration on probing (BOP/SoP) and radiologically assessed marginal bone loss ≥ 3 mm), 3. had received treatment for peri-implantitis at least 5 years ago at the Graduate Clinic of Periodontics at University of Michigan, and 4. documentation from ≥ 5 years of clinical and radiological follow-up is available from U of M patients records.

Exclusion criteria

1. Has received or is currently receiving radiotherapy, 2. are currently pregnant, unsure of their pregnancy status, or are lactating (as reported by the patient), 3. has health condition(s) or takes medication(s) that are known to affect soft tissue or bone (e.g., Phenytoin)

Design outcomes

Primary

MeasureTime frameDescription
Therapeutic resolution of the peri-implantitis as measured by radiographic bone lossAt least five years after the implant was treated for peri-implantitisThe implant has no further radiographic bone loss when compared to previous radiographs.
Therapeutic resolution of the peri-implantitis as measured by erythemaAt least five years after the implant was treated for peri-implantitisThe implant has no current erythema of the peri-implant mucosa.
Therapeutic resolution of the peri-implantitis as measured by probing depthsAt least five years after the implant was treated for peri-implantitisThe implant has probing depths less than or equal to 5 millimeters.
Survival rate of the peri-implantitis treated dental implantsAt least five years after the implant was treated for peri-implantitisSurvival rate will be determined by the duration of implant survival (functioning, non-symptomatic implant after peri-implantitis treatment).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026